Cutaneous Leishmaniasis Diagnostic Study
NCT03837431 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 351
Last updated 2023-03-01
Summary
The performance of the CL Detect Rapid test will be tested in individuals with suspected cutaneous leishmaniasis in Ethiopia using both skin slit and dental broach samples against a combined reference of microscopy and PCR. Alternative sampling methods will also be evaluated.
Conditions
- Cutaneous Leishmaniases
Interventions
- DIAGNOSTIC_TEST
-
Skin slit
Skin slit microscopy, RDT and PCR
- DIAGNOSTIC_TEST
-
Dental broach
Dental broach RDT and PCR
- DIAGNOSTIC_TEST
-
Tape disc
Tape disc PCR
Sponsors & Collaborators
-
Institute of Tropical Medicine, Belgium
lead OTHER
Principal Investigators
-
Johan van Griensven, MD, PhD · Institute of Tropical Medicine, Antwerp, Belgium
-
Rezika Mohammed, MD · College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
Eligibility
- Min Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-02-13
- Primary Completion
- 2022-08-12
- Completion
- 2023-01-31
Countries
- Ethiopia
Study Locations
More Related Trials
-
LAMP Assay for the Diagnosis of Visceral Leishmaniasis
NCT04003532 ·Status: COMPLETED
-
Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of Cure
NCT05426577 ·Status: UNKNOWN
-
Tofacitinib Associated With Meglumine Antimoniate in Cutaneous Leishmaniasis
NCT06011343 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study
NCT01360762 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis
NCT00111553 ·Status: COMPLETED ·Phase: PHASE1
-
Outcomes of Complicated CL in Ethiopia Treated With Miltefosine
NCT04004754 ·Status: COMPLETED
-
OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis Patients
NCT06514560 ·Status: RECRUITING
-
Trial of Miltefosine in Cutaneous Leishmaniasis (Brazil)
NCT00600548 ·Status: COMPLETED ·Phase: PHASE2
-
Visceral Leishmaniasis and Malnutrition in Amhara Regional State, Ethiopia
NCT02148822 ·Status: COMPLETED
-
ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE -
NCT03303898 ·Status: COMPLETED ·Phase: NA
-
Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis.
NCT06000514 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia
NCT00537953 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis
NCT01301924 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Investigation of Infections Due to Leishmanial Parasites
NCT00001169 ·Status: COMPLETED
-
Low Antimonial Dosage in American Mucosal Leishmaniasis
NCT01301937 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Human Leishmaniasis: Antigen Recognition Pattern and Study of New Potential Biomarkers
NCT06307171 ·Status: RECRUITING ·Phase: NA
-
ELISA Validation of Hypersensitive Rapid Diagnostic Test Results for Detection of P. Falciparum
NCT03132402 ·Status: COMPLETED
-
Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study
NCT06118749 ·Status: TERMINATED
-
Miltefosine and GM-CSF in Cutaneous Leishmaniasis
NCT03023111 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Prognostic Score to Predict Relapse in VL
NCT05602610 ·Status: RECRUITING
-
Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World
NCT00703924 ·Status: COMPLETED ·Phase: PHASE2
-
Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis
NCT00257530 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly
NCT06040489 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Surveillance for Leishmaniasis Skin Lesions in Mali
NCT00344084 ·Status: COMPLETED
-
Performance of RPA-LF for Cutaneous Leishmaniasis
NCT04500873 ·Status: COMPLETED